GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (OTCPK:BIESF) » Definitions » Cyclically Adjusted PB Ratio

Biotest AG (Biotest AG) Cyclically Adjusted PB Ratio : 3.35 (As of Jun. 09, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Biotest AG Cyclically Adjusted PB Ratio?

As of today (2024-06-09), Biotest AG's current share price is $30.48. Biotest AG's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $9.09. Biotest AG's Cyclically Adjusted PB Ratio for today is 3.35.

The historical rank and industry rank for Biotest AG's Cyclically Adjusted PB Ratio or its related term are showing as below:

BIESF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.61   Med: 2.84   Max: 3.75
Current: 3.24

During the past years, Biotest AG's highest Cyclically Adjusted PB Ratio was 3.75. The lowest was 1.61. And the median was 2.84.

BIESF's Cyclically Adjusted PB Ratio is ranked worse than
68.84% of 661 companies
in the Biotechnology industry
Industry Median: 1.75 vs BIESF: 3.24

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Biotest AG's adjusted book value per share data for the three months ended in Mar. 2024 was $14.500. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $9.09 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Biotest AG Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Biotest AG's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG Cyclically Adjusted PB Ratio Chart

Biotest AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.72 2.54 3.61 3.43 3.39

Biotest AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.35 3.36 3.38 3.39 3.35

Competitive Comparison of Biotest AG's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Biotest AG's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotest AG's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biotest AG's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Biotest AG's Cyclically Adjusted PB Ratio falls into.



Biotest AG Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Biotest AG's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=30.48/9.09
=3.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotest AG's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Biotest AG's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=14.5/125.0381*125.0381
=14.500

Current CPI (Mar. 2024) = 125.0381.

Biotest AG Quarterly Data

Book Value per Share CPI Adj_Book
201406 16.069 99.543 20.185
201409 15.850 99.823 19.854
201412 14.960 99.543 18.792
201503 13.751 99.717 17.243
201506 13.725 100.417 17.090
201509 11.291 100.417 14.059
201512 11.347 99.717 14.228
201603 11.535 100.017 14.421
201606 11.829 100.717 14.685
201609 11.541 101.017 14.285
201612 9.610 101.217 11.872
201703 9.073 101.417 11.186
201706 9.634 102.117 11.796
201709 9.976 102.717 12.144
201712 10.452 102.617 12.736
201803 10.591 102.917 12.867
201806 14.726 104.017 17.702
201809 14.894 104.718 17.784
201812 14.231 104.217 17.074
201903 14.103 104.217 16.921
201906 14.169 105.718 16.758
201909 13.685 106.018 16.140
201912 13.391 105.818 15.823
202003 13.018 105.718 15.397
202006 13.071 106.618 15.329
202009 13.222 105.818 15.624
202012 13.576 105.518 16.088
202103 12.867 107.518 14.964
202106 12.861 108.486 14.823
202109 12.255 109.435 14.002
202112 10.862 110.384 12.304
202203 10.440 113.968 11.454
202206 9.582 115.760 10.350
202209 8.602 118.818 9.052
202212 9.934 119.345 10.408
202303 9.500 122.402 9.705
202306 10.226 123.140 10.384
202309 12.403 124.195 12.487
202312 13.749 123.773 13.890
202403 14.500 125.038 14.500

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biotest AG  (OTCPK:BIESF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Biotest AG Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Biotest AG's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotest AG (Biotest AG) Business Description

Industry
Traded in Other Exchanges
Address
Landsteinerstrasse 5, Dreieich, DEU, 63303
Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.

Biotest AG (Biotest AG) Headlines

From GuruFocus

Q4 2021 Biotest AG Earnings Call Transcript

By GuruFocus Research 03-03-2024

Q4 2022 Biotest AG Earnings Call Transcript

By GuruFocus Research 03-03-2024

Q3 2021 Biotest AG Earnings Call Transcript

By GuruFocus Research 03-03-2024

Full Year 2019 Biotest AG Earnings Call Transcript

By GuruFocus Research 03-03-2024

Nine Months 2020 Biotest AG Earnings Call Transcript

By GuruFocus Research 03-03-2024

Q4 2020 Biotest AG Earnings Call Transcript

By GuruFocus Research 03-03-2024

Nine Months 2019 Biotest AG Earnings Call Transcript

By GuruFocus Research 03-03-2024

Q3 2022 Biotest AG Earnings Call Transcript

By GuruFocus Research 03-03-2024